Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience our own tag's counts — open to see them
–Visits
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · visits, page views and clicks counted by our own tag, which counts more than our checked analytics; every figure rounded down · how we count

Head-to-head · AI Drug Discovery Software

Pharma.AI vs Recursion

  • Updated Oct 2026
  • Both researched from official sources
  • 5 checks side by side
Higher score Pharma.AI #2 in AI Drug Discovery Software 8.8/10 Pricing on request ✓ 4 of 4 features Contact Insilico
Recursion #3 in AI Drug Discovery Software 8.7/10 Pricing on request ✓ 3 of 4 features Visit Recursion

Pharma.AI leads on 0 checks, Recursion on 0, and 5 are even. Who comes out ahead on the 5 yes/no, price and count checks where we have data for both products. The editor score weighs everything else too.

Our verdict

  • Highest scorePharma.AI · 8.8/10
  • Most featuresPharma.AI · 4 of 4

Pharma.AI scores higher on our rubric for ai drug discovery software: 8.8 against 8.7 out of 10; our editors rank them #2 and #3.

Pharma.AI is the better fit for teams seeking a broad discovery and research suite. Recursion is the better fit for teams linking computational discovery to experiments.

  • Pharma.AI fits best

    Teams seeking a broad discovery and research suite

  • Recursion fits best

    Teams linking computational discovery to experiments

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.

Side by side

Feature Pharma.AI 8.8/10 Visit ↗ Recursion 8.7/10 Visit ↗
At a glance
Editor score 8.8 8.7
Ranking #2 in AI Drug Discovery Software #3 in AI Drug Discovery Software
Best for Teams seeking a broad discovery and research suite Teams linking computational discovery to experiments
Pricing model Paid Paid
Starting price Pricing on request Pricing on request
Free plan Not checked yet —
Free trial — —
Built for Mid-market, Enterprise Mid-market, Enterprise
Features Pharma.AI 4/4 · Recursion 3/4
Target identification ✓ ✓
Molecule design ✓ ✓
Drug repurposing ✓ (best) Not checked yet
Research publications ✓ ✓
Specs
Discovery scope Suite Suite
Deployment options Not checked yet Not checked yet
Our review
Pros
  • Analyzes multi-omics and text evidence for target prioritization
  • Supports small-molecule and biologics design and optimization
  • Includes repositioning, clinical-trial prediction and research workflows
  • Connects target identification, molecule design and ADMET computation.
  • Combines machine-learning analysis of biological and chemical data.
  • Schedules synthesis and experiments, with results feeding computational workflows.
Cons
  • Pricing requires contacting Insilico Medicine
  • Access is cloud-based, with web listed as the platform
  • Broad scope may not suit teams seeking a focused single-stage tool
  • No free plan is available.
  • Pricing is handled through sales rather than public plan tiers.
  • The proprietary Recursion OS is not open source.
Our verdict

Pharma.AI is Insilico Medicine’s commercial software suite for pharmaceutical research and development. It is aimed at mid-market and enterprise R&D teams that want computational support across multiple stages of discovery. PandaOmics…

Read the review →

Recursion OS brings computational drug discovery and physical experimentation into one platform, with workflows that span target identification through molecule design and onward into development. Its capabilities include machine-learning…

Read the review →
  1. Pharma.AIAI Drug Discovery Software 8.8Pricing on request
  2. RecursionAI Drug Discovery Software 8.7Pricing on request

Strengths and trade-offs

  • Pharma.AI — where it wins

    • Analyzes multi-omics and text evidence for target prioritization
    • Supports small-molecule and biologics design and optimization
    • Includes repositioning, clinical-trial prediction and research workflows

    Where it doesn't

    • Pricing requires contacting Insilico Medicine
    • Access is cloud-based, with web listed as the platform
    • Broad scope may not suit teams seeking a focused single-stage tool

  • Recursion — where it wins

    • Connects target identification, molecule design and ADMET computation.
    • Combines machine-learning analysis of biological and chemical data.
    • Schedules synthesis and experiments, with results feeding computational workflows.

    Where it doesn't

    • No free plan is available.
    • Pricing is handled through sales rather than public plan tiers.
    • The proprietary Recursion OS is not open source.
  • Pharma.AI8.8/10 · Pricing on request

    A broad discovery suite spanning target research, molecule design and clinical-trial prediction.

    Contact InsilicoFull verdict →
  • Recursion8.7/10 · Pricing on request

    A broad discovery suite for teams connecting computational models with lab experiments.

    Visit RecursionFull verdict →

More comparisons

All AI drug discovery software comparisons → · Full ranking →

Guides on AI drug discovery software

Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026

Last updated · How we research and update